VSL LABORATORIES LIMITED

Credit Analysis: VSL LABORATORIES LIMITED

1. Credit Opinion: APPROVE

Reasoning: The company demonstrates strong recent financial performance, ample liquidity, and a healthy balance sheet. The significant improvement in net assets and cash position in FY2025, combined with manageable debt levels and a clear ability to service obligations, supports an approval for a credit facility. The sole director’s control is concentrated, but the business has shown consistent activity and filing compliance. The main risk is the volatility of historical net assets, but the current trajectory is positive.

2. Financial Strength

• Net Assets: £33,042 (FY2025) vs £7,781 (FY2024) – a 324% increase, driven by retained earnings growth.
• Shareholders’ Funds: £32,942 (FY2025), indicating a solid equity base relative to total assets of £75,738.
• Gearing: Total bank loans of £10,888 (current + long-term) represent 33% of shareholders’ funds – moderate and declining as the loan is being repaid (down from £15,004 in FY2024).
• Asset Quality: No significant fixed assets (£2,000 tangible), but debtors are largely trade (91% of total debtors) and cash is substantial. No stock/inventory, which reduces working capital risk but also implies reliance on trade debtors.
• Historical Volatility: Net assets fluctuated between £166 and £8,698 in previous years, so the FY2025 jump is notable but not yet proven as sustainable. The trend from FY2022 onwards is upward.

3. Cash Flow Assessment

• Liquidity: Cash at bank £43,682, covering current liabilities (£35,971) by 1.2x on a pure cash basis and 2.05x when including debtors. No overdraft reliance beyond the bank loan current portion (£4,543).
• Working Capital: Net current assets of £37,767 (current assets £73,738 minus current liabilities £35,971) – a strong positive position. Debtors (30 days of sales, estimated) are manageable.
• Debt Servicing: The bank loan of £10,888 is being repaid in instalments (£4,543 due within one year). Annual profit (implied: ~£75k after tax in FY2025) comfortably covers debt service. Dividend payments of £50,000 in FY2025 further confirm cash generation.
• Director’s Loan: Reduced from £11,665 to £1,899 during the year, with net repayments. This is a positive sign of financial discipline.

4. Monitoring Points

• Sustainability of Profitability: The FY2025 profit surge needs to be confirmed in subsequent periods. Monitor future retained earnings and dividend policy.
• Corporation Tax Liability: £22,033 payable within one year is a significant short-term obligation. Ensure cash flow remains sufficient post-dividend.
• Trade Debtor Concentration: Debtors are £27,317. If concentrated among a few customers, credit risk increases. Request a debtor ageing schedule.
• Director Dependency: The sole director (Xxxxxx Xxxxxxxxname shown to subscribers) holds >75% control. Key-person risk should be considered; a life cover or key-person insurance may be prudent.
• Bank Loan Repayment: Track the reduction in the long-term loan balance to ensure compliance with covenant-free terms.

Names of the people mentioned are shown to subscribers. See subscription